Abstract:The coronavirus disease 2019 (COVID-19) pandemic caused extensive loss of life worldwide. Further, the COVID-19 and influenza mix-infection had caused great distress to the diagnosis of the disease. To control illness progression and limit viral spread within the population, a real-time reverse-transcription PCR (RT-PCR) assay for early diagnosis of COVID-19 was developed, but detection was time-consuming (4-6 h). To improve the diagnosis of COVID-19 and influenza, we herein developed a recombinase polymerase amplification (RPA) method for simple and rapid amplification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 and Influenza A (H1N1, H3N2) and B (influenza B). Genes encoding the matrix protein (M) for H1N1, and the hemagglutinin (HA) for H3N2, and the polymerase A (PA) for Influenza B, and the nucleocapsid protein (N), the RNA-dependent-RNA polymerase (RdRP) in the open reading frame 1ab (ORF1ab) region, and the envelope protein (E) for SARS-CoV-2 were selected, and specific primers were designed. We validated our method using SARS-CoV-2, H1N1, H3N2 and influenza B plasmid standards and RNA samples extracted from COVID-19 and Influenza A/B (RT-PCR-verified) positive patients. The method could detect SARS-CoV-2 plasmid standard DNA quantitatively between 10(2) and 10(5) copies/ml with a log linearity of 0.99 in 22 min. And this method also be very effective in simultaneous detection of H1N1, H3N2 and influenza B. Clinical validation of 100 cases revealed a sensitivity of 100% for differentiating COVID-19 patients from healthy controls when the specificity was set at 90%. These results demonstrate that this nucleic acid testing method is advantageous compared with traditional PCR and other isothermal nucleic acid amplification methods in terms of time and portability. This method could potentially be used for detection of SARS-CoV-2, H1N1, H3N2 and influenza B, and adapted for point-of-care (POC) detection of a broad range of infectious pathogens in resource-limited settings.

Clinical diagnostic significance of tests of viral genes and specific antibodies for severe H1N1 influenza A

Surveillance of influenza A virus in Beijing from 2009-2010

An epidemiological study of H1N1 influenza A

The need for strengthening the influenza virus detection ability of hospital clinical laboratories: an investigation of the 2009 pandemic

Rapid diagnostic tests for identifying avian influenza A(H7N9) virus in clinical samples.

Dynamic Variations in the Peripheral Blood Lymphocyte Subgroups of Patients with 2009 Pandemic H1N1 Swine-Origin Influenza A Virus Infection

Comparison of a New Gold Immunochromatographic Assay for the Rapid Diagnosis of the Novel Influenza A (H7N9) Virus with Cell Culture and a Real-Time Reverse-Transcription PCR Assay.

Nucleic Acid of Influenza A Virus(H1N1)Detected in Blood and Urine Samples of H1N1 Patients

Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study

A Combination Of Serological Assays To Detect Human Antibodies To The Avian Influenza A H7n9 Virus

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013.

A Highly Specific ELISA for Diagnosis of 2009 Influenza A (H1N1) Virus Infections.

Study on the sensitivity of different primers at detecting nucleic acids of the influenza A H1N1 virus

Development and Comparison of Molecular Assays for the Rapid Detection of the Pandemic Influenza A (H1N1) 2009 Virus

[Evaluating the current protocol of influenza A (H1N1) based on the epidemic situations of Zhengzhou,a middle-sized city in China]

Detection of serum influenza antibody in Nanchang during 2005~2006

The diagnostic value of joint detection of serum IgM and IgG antibodies to 2019-nCoV in 2019-nCoV infection

Detection of Human Novel Influenza A (H1N1) Viruses Using Multi-Fluorescent Real-Time RT-PCR

Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19

Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients